This inventor holds 2 USPTO granted patents. Top assignees: Affymax Technologies, N.v., Hoechst Marion Roussel. Active years: 1998-1999.
Company Filing History:
2 out of 88 
2 out of 236 Years Active: 1998-1999
Title: Ellen M Leahy: Innovator in Peptide Research
Introduction
Ellen M Leahy is a prominent inventor based in San Leandro, CA (US). She has made significant contributions to the field of peptide research, particularly in the development of compounds that interact with the interleukin-1 receptor. With a total of 2 patents, her work has implications for various therapeutic applications.
Latest Patents
Ellen's latest patents focus on peptides and compounds that bind to the IL-1 receptor. These peptides can be utilized to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample. The sequences of amino acids in these peptides are carefully selected to ensure their effectiveness. The core sequences include variations that allow for binding to the interleukin-1 type I receptor (IL-1RtI), showcasing her innovative approach to peptide design.
Career Highlights
Throughout her career, Ellen has worked with notable companies such as Affymax Technologies and Hoechst Marion Roussel. Her experience in these organizations has contributed to her expertise in peptide research and development. Ellen's work has not only advanced scientific understanding but also paved the way for potential therapeutic solutions.
Collaborations
Ellen has collaborated with esteemed colleagues, including Stephen D Yanofsky and Ronald W Barrett. These partnerships have enriched her research and expanded the impact of her innovations in the field.
Conclusion
Ellen M Leahy's contributions to peptide research and her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to influence the development of new therapeutic strategies.